XWELL (NASDAQ:XWEL – Get Free Report) and Establishment Labs (NASDAQ:ESTA – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, risk, institutional ownership and dividends.
Volatility & Risk
XWELL has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500.
Valuation and Earnings
This table compares XWELL and Establishment Labs”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| XWELL | $33.90 million | 0.11 | -$16.85 million | ($3.37) | -0.19 |
| Establishment Labs | $166.02 million | 13.03 | -$84.60 million | ($2.84) | -26.20 |
XWELL has higher earnings, but lower revenue than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than XWELL, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent ratings and price targets for XWELL and Establishment Labs, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| XWELL | 1 | 0 | 0 | 0 | 1.00 |
| Establishment Labs | 1 | 1 | 6 | 0 | 2.63 |
Establishment Labs has a consensus target price of $78.14, indicating a potential upside of 5.00%. Given Establishment Labs’ stronger consensus rating and higher probable upside, analysts plainly believe Establishment Labs is more favorable than XWELL.
Insider and Institutional Ownership
8.7% of XWELL shares are owned by institutional investors. Comparatively, 72.9% of Establishment Labs shares are owned by institutional investors. 13.9% of XWELL shares are owned by company insiders. Comparatively, 11.1% of Establishment Labs shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares XWELL and Establishment Labs’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| XWELL | -51.85% | -352.37% | -64.88% |
| Establishment Labs | -43.45% | -235.45% | -22.83% |
Summary
Establishment Labs beats XWELL on 10 of the 14 factors compared between the two stocks.
About XWELL
XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs. The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.
About Establishment Labs
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Receive News & Ratings for XWELL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XWELL and related companies with MarketBeat.com's FREE daily email newsletter.
